Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.

Novosad SA, Mu Y, Winston LG, Johnston H, Basiliere E, Olson DM, Farley MM, Revis A, Wilson L, Perlmutter R, Holzbauer SM, Whitten T, Phipps EC, Dumyati GK, Beldavs ZG, Ocampo VLS, Davis CM, Kainer M, Gerding DN, Guh AY.

J Gen Intern Med. 2020 Feb;35(2):412-419. doi: 10.1007/s11606-019-05386-9. Epub 2019 Nov 25.

PMID:
31768906
2.

Compliance with statewide regulations for communication of patients' multidrug-resistant organism and Clostridium difficile status during transitions of care.

Ellingson KD, Noble BN, Tran D, Buser GL, Pfeiffer CD, Cassidy PM, Pierce R, Beldavs ZG, Furuno JP.

Am J Infect Control. 2019 Oct 8. pii: S0196-6553(19)30806-5. doi: 10.1016/j.ajic.2019.08.025. [Epub ahead of print]

PMID:
31604624
3.

Risk factors for community-associated Clostridioides difficile infection in young children.

Weng MK, Adkins SH, Bamberg W, Farley MM, Espinosa CC, Wilson L, Perlmutter R, Holzbauer S, Whitten T, Phipps EC, Hancock EB, Dumyati G, Nelson DS, Beldavs ZG, Ocampo V, Davis CM, Rue B, Korhonen L, McDonald LC, Guh AY.

Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372.

4.

Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010-2016.

Buser GL, Laidler MR, Cassidy PM, Moulton-Meissner H, Beldavs ZG, Cieslak PR.

Emerg Infect Dis. 2019 May;25(5):849-855. doi: 10.3201/eid2505.181687.

5.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC.

Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.

6.

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015.

Benedict K, Roy M, Kabbani S, Anderson EJ, Farley MM, Harb S, Harrison LH, Bonner L, Wadu VL, Marceaux K, Hollick R, Beldavs ZG, Zhang AY, Schaffner W, Graber CR, Derado G, Chiller TM, Lockhart SR, Vallabhaneni S.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e78-e85. doi: 10.1093/jpids/piy009.

PMID:
29522195
7.

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Guh AY, Mu Y, Baggs J, Winston LG, Bamberg W, Lyons C, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, Dumyati G.

Am J Infect Control. 2018 Jul;46(7):840-842. doi: 10.1016/j.ajic.2017.11.026. Epub 2018 Jan 9.

8.

Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing blaOXA-237 Carried on a Plasmid.

Hujer AM, Higgins PG, Rudin SD, Buser GL, Marshall SH, Xanthopoulou K, Seifert H, Rojas LJ, Domitrovic TN, Cassidy PM, Cunningham MC, Vega R, Furuno JP, Pfeiffer CD, Beldavs ZG, Wright MS, Jacobs MR, Adams MD, Bonomo RA.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00797-17. doi: 10.1128/AAC.00797-17. Print 2017 Nov.

9.

Failure to Communicate: Transmission of Extensively Drug-Resistant bla OXA-237-Containing Acinetobacter baumannii-Multiple Facilities in Oregon, 2012-2014.

Buser GL, Cassidy PM, Cunningham MC, Rudin S, Hujer AM, Vega R, Furuno JP, Marshall SH, Higgins PG, Jacobs MR, Wright MS, Adams MD, Bonomo RA, Pfeiffer CD, Beldavs ZG.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1335-1341. doi: 10.1017/ice.2017.189. Epub 2017 Sep 5.

10.

New Delhi metallo-β-lactamase-1 (NDM-1) Escherichia coli isolated from household vacuum cleaner-Oregon, 2013.

Buser GL, Cassidy PM, Pfeiffer CD, Townes JM, Morey KE, Rayar J, Kutumbaka KK, Han S, Nadala C, Samadpour M, Weissman SJ, Vega R, Beldavs ZG.

IDCases. 2017 Jun 15;9:56-58. doi: 10.1016/j.idcr.2017.06.004. eCollection 2017.

11.

Evaluation of the Carba NP Test in Oregon, 2013.

Morey KE, Vega R, Cassidy PM, Buser GL, Rayar JK, Myers JA, Weissman SJ, Beldavs ZG, Pfeiffer CD.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e03005-15. doi: 10.1128/AAC.03005-15. Print 2017 Jan.

12.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196. doi: 10.1093/ofid/ofv196. eCollection 2016 Jan.

13.

Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014.

Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, Derado G, Pham CD, Lockhart SR, Smith RM.

Open Forum Infect Dis. 2015 Dec 14;2(4):ofv163. doi: 10.1093/ofid/ofv163. eCollection 2015 Dec.

14.

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

15.

Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multicenter evaluation.

Thompson ND, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Godine D, Maloney M, Kainer M, Ray S, Thompson D, Wilson L, Magill SS.

Am J Infect Control. 2015 Aug;43(8):853-6. doi: 10.1016/j.ajic.2015.03.031. Epub 2015 May 21.

16.

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations.

Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK.

Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. doi: 10.1093/ofid/ofu048. eCollection 2014 Sep.

17.

Burden of Clostridium difficile infection in the United States.

Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC.

N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.

18.

Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.

Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

JAMA. 2014 Oct 8;312(14):1438-46. doi: 10.1001/jama.2014.12923.

PMID:
25291579
19.

Much to do about carbapenem-resistant Enterobacteriaceae: why supplementing surveillance may be the key to stopping spread.

Pfeiffer CD, Beldavs ZG.

Infect Control Hosp Epidemiol. 2014 Aug;35(8):984-5. doi: 10.1086/677158. Epub 2014 Jun 20. No abstract available.

PMID:
25026613
20.

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.

Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, Schaffner W, Beldavs ZG, Chiller TM, Park BJ, Cleveland AA, Lockhart SR.

Antimicrob Agents Chemother. 2014 Aug;58(8):4690-6. doi: 10.1128/AAC.03255-14. Epub 2014 Jun 2.

21.

Draft Genome Sequence of blaNDM-1-Positive Escherichia coli O25b-ST131 Clone Isolated from an Environmental Sample.

Kutumbaka KK, Han S, Mategko J, Nadala C, Buser GL, Cassidy MP, Beldavs ZG, Weissman SJ, Morey KE, Vega R, Samadpour M.

Genome Announc. 2014 May 29;2(3). pii: e00462-14. doi: 10.1128/genomeA.00462-14.

22.

Multistate point-prevalence survey of health care-associated infections.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.

23.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC.

Clin Infect Dis. 2014 May;58(10):1394-400. doi: 10.1093/cid/ciu125. Epub 2014 Mar 5.

24.

Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.

Pfeiffer CD, Cunningham MC, Poissant T, Furuno JP, Townes JM, Leitz A, Thomas A, Buser GL, Arao RF, Beldavs ZG.

Infect Control Hosp Epidemiol. 2014 Apr;35(4):356-61. doi: 10.1086/675605.

PMID:
24602939
25.

Clostridium difficile infection among children across diverse US geographic locations.

Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC.

Pediatrics. 2014 Apr;133(4):651-8. doi: 10.1542/peds.2013-3049. Epub 2014 Mar 3.

PMID:
24590748
26.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC.

JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.

PMID:
23780507
27.

Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methods.

Thompson ND, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Godine D, Maloney M, Kainer M, Ray S, Thompson D, Wilson L, Magill SS.

Infect Control Hosp Epidemiol. 2013 Mar;34(3):221-8. doi: 10.1086/669515. Epub 2013 Jan 24.

PMID:
23388355
28.

Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.

Oh JY, Cunningham MC, Beldavs ZG, Tujo J, Moore SW, Thomas AR, Cieslak PR.

Infect Control Hosp Epidemiol. 2012 May;33(5):439-45. doi: 10.1086/665317. Epub 2012 Mar 21.

PMID:
22476268
29.

Testing the Oregon delinquency model with 9-year follow-up of the Oregon Divorce Study.

Forgatch MS, Patterson GR, Degarmo DS, Beldavs ZG.

Dev Psychopathol. 2009 Spring;21(2):637-60. doi: 10.1017/S0954579409000340.

PMID:
19338702
30.

An efficacious theory-based intervention for stepfamilies.

Forgatch MS, Degarmo DS, Beldavs ZG.

Behav Ther. 2005;36(4):357-65.

Supplemental Content

Loading ...
Support Center